STALEVO
STALEVO
Approved
DIN Number
02305933
Drug Class
Human
Market Date
Apr 28, 2008
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02305933
AIG Number0352427001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N04BA03 LEVODOPA,DECARBOXYLASE INHIBITOR, AND COMT INHIBITOR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:36.12
Health Canada Classification
ACTIVE INGREDIENTS (3)
CARBIDOPAActive
Strength: 12.5 MG
Monograph: CARBIDOPA
ENTACAPONEActive
Strength: 200 MG
Monograph: ENTACAPONE
LEVODOPAActive
Strength: 50 MG
Monograph: LEVODOPA